Drugs / Vertistop® D
last change Sep 2019 re-read 3 minutes ago

Vertistop® D

Developed for
benign paroxysmal positional vertigo
Investigated by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Trials 1

20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05748249 Nov 2018 → Sep 2019 benign paroxysmal positional vertigo, nutritional disorder Fondazione Policlinico Universitario Agostino Gemelli IRCCS Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Vertistop D ClinicalTrials.gov intervention name — accepted as the source's own label NCT05748249 ↗